drugset / Press release
Dizal Announces NMPA Acceptance of IND Application for DZD9008
2019-04-28 · Dizal Pharmaceuticals · original dizalpharma.com ↗
April 26, 2019 (GMT+8) – China National Medical Products Administration (NMPA) accepted IND application for DZD9008.
The release as fetched from its publisher. dizalpharma.com ↗